Tenaya Therapeutics, Inc. (TNYA) has a MoatMap StockRank of 3/100 based on Quality (26/100), Value (38/100), and Momentum (13/100) factor scores. The current signal is STRONG SELL.
Tenaya Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to discovering, developing, and delivering curative therapies for heart disease. Its competitive moat lies in its integrated product discovery platform that combines gene therapy, cellular regeneration, and precision medicine approaches for genetically defined cardiovascular conditions. Tenaya is a focused player in the burgeoning field of cardiovascular genetic medicines, aiming to transform the treatment paradigm for severe heart diseases.
| Price | $0.77 |
| Market Cap | $168M |
| P/E (Forward) | -1.90 |
| Price/Book | 1.38 |
| Return on Equity | -73.6% |
| Return on Invested Capital | -71.0% |
| Debt/Equity | 9.53 |
| Gross Margin | 100.0% |
| Operating Margin | -8917.8% |
| Free Cash Flow | $-40M |
Tenaya Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).